Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin–paclitaxel for chemo-naïve non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002)
Akira Inoue(Tohoku University Hospital), Kunihiko Kobayashi(Saitama Medical University), Makoto Maemondo(Miyagi Prefectural Hospital Organization), Shunichi Sugawara(Sendai Kousei Hospital), Satoshi Oizumi(Hokkaido University), Hiroshi Isobe(NTT Medical Center), Akihiko Gemma, M. Harada(National Hospital Organization Hokkaido Medical Center), Hirohisa Yoshizawa(Niigata University Medical and Dental Hospital), Ichiro Kinoshita(Sapporo Medical University), Yasuko Fujita(National Hospital Organization), Shoji Okinaga, Haruto Hirano(Iwate Prefectural Central Hospital), Kozo Yoshimori(Fukujuji Hospital), Toshiyuki Harada(Hokkaido hospital), Yasuo Saijo(Hirosaki University), Koichi Hagiwara(Saitama Medical University), Satoshi Morita(Yokohama City University Medical Center), T. Nukiwa(Tohoku University Hospital)
Cited by 553
Abstract
Related Papers
No related papers found
Powered by citation graph analysis